Pt involved in clinical trial (this event was reported also by study coordinators to the appropriate regulatory authority) with a parp inhibitor and an alkylating chemotherapy.She was also using optune device (tumor treating field).Her liver enzymes have been gradually increasing over the last 2-3 weeks, but the values spikes yesterday.This lead to her hospitalization.It was not likely to be related to device, as she had been wearing the device significantly longer than taking the study drug and chemotherapy.
|